An integrated approach to the treatment of infectious lesions of the upper respiratory tract in pediatric practice

Introduction . The article substantiates a comprehensive bioregulatory approach to the treatment and immunorehabilitation of infectious respiratory diseases of the upper respiratory tract in pediatric practice. Aim . To study the efficacy and tolerability of a bioregulatory drug in the complex treatment of children with infectious lesions of the upper respiratory tract. Materials and methods . A prospective single-center study was conducted, 63 children: the main group of 32 children, the bioregulatory drug Tonsilgon® N 14 days was included in the complex of generally accepted therapy; 31 – the control group, only a complex of generally accepted therapy providing an anti-inflammatory effect was carried out. The age of children was 3–5 (4.3 ± 0.37) and 6–12 (9.2 ± 1.48) years in equal numbers by gender. Verification of the pathogen was carried out upon admission: in the main group, group A β-hemolytic streptococcus was detected in 7 (21.87%) patients, in the control group – in 6 (19.35%) patients; In the main group, Ig to Chlamydophila pneumoniae and Mycoplasma pneumoniae were in 9 (28.12%) patients, in the control group – 8 (25.8%), systemic antimicrobial therapy was prescribed. Results . In the main group, on the 3rd day of examination, the treatment was assessed as highly effective in 21 (65.62%), effective in 10 (31.25%), and moderately effective in 1 (3.12%). On average, the effectiveness score for the group was 2.61 ± 0.14 points. Discussion. The broad spectrum of action, due to the diverse composition of the phytoimmunomodulator, has a stimulating effect on the activation of phagocytosis of macrophages and granulocytes, accelerating the elimination of pathogens, which is consistent with our data and with literature data. Conclusions . An integrated approach to the treatment of inflammatory diseases of the oral cavity in children with the inclusion of a bioregulatory drug has a beneficial effect on the course of the inflammatory process in the oropharynx and stimulates the body’s resistance.

Authors

Institutions

Publication Details

Journal
Meditsinskiy sovet = Medical Council
Published
2025-04-03
DOI
https://doi.org/10.21518/ms2025-027
Primary Topic
Sinusitis and nasal conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An integrated approach to the treatment of infectious lesions of the upper respiratory tract in pediatric practice

A. M. Zakirov, A. A. Kadriev, Х. М. Вахитов, Р. А. Файзуллина et al.
Meditsinskiy sovet = Medical Council
Sinusitis and nasal conditions
article

An integrated approach to the treatment of infectious lesions of the upper respiratory tract in pediatric practice

A. M. Zakirov, A. A. Kadriev, Х. М. Вахитов, Р. А. Файзуллина, Т. Б. Мороз, A. I. Klyushkina, A. G. Kadriev, А. М. Закирова, Е. L. Rashitova, I. A. Sherifova
article en

Abstract

Introduction . The article substantiates a comprehensive bioregulatory approach to the treatment and immunorehabilitation of infectious respiratory diseases of the upper respiratory tract in pediatric practice. Aim . To study the efficacy and tolerability of a bioregulatory drug in the complex treatment of children with infectious lesions of the upper respiratory tract. Materials and methods . A prospective single-center study was conducted, 63 children: the main group of 32 children, the bioregulatory drug Tonsilgon® N 14 days was included in the complex of generally accepted therapy; 31 – the control group, only a complex of generally accepted therapy providing an anti-inflammatory effect was carried out. The age of children was 3–5 (4.3 ± 0.37) and 6–12 (9.2 ± 1.48) years in equal numbers by gender. Verification of the pathogen was carried out upon admission: in the main group, group A β-hemolytic streptococcus was detected in 7 (21.87%) patients, in the control group – in 6 (19.35%) patients; In the main group, Ig to Chlamydophila pneumoniae and Mycoplasma pneumoniae were in 9 (28.12%) patients, in the control group – 8 (25.8%), systemic antimicrobial therapy was prescribed. Results . In the main group, on the 3rd day of examination, the treatment was assessed as highly effective in 21 (65.62%), effective in 10 (31.25%), and moderately effective in 1 (3.12%). On average, the effectiveness score for the group was 2.61 ± 0.14 points. Discussion. The broad spectrum of action, due to the diverse composition of the phytoimmunomodulator, has a stimulating effect on the activation of phagocytosis of macrophages and granulocytes, accelerating the elimination of pathogens, which is consistent with our data and with literature data. Conclusions . An integrated approach to the treatment of inflammatory diseases of the oral cavity in children with the inclusion of a bioregulatory drug has a beneficial effect on the course of the inflammatory process in the oropharynx and stimulates the body’s resistance.

Meditsinskiy sovet = Medical Council(1)
Kazan State Medical University (RU), Center for Children (US), Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology (RU), City Clinical Hospital (RU)
Openalex Percentile: Top 91%
Sinusitis and nasal conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.